Lahmy S, Lautier D, Canitrot Y, Laurent G, Salmon J M
Université de Perpignan, France.
Leuk Res. 1993 Dec;17(12):1021-9. doi: 10.1016/0145-2126(93)90158-h.
Development of resistance is the major cause of failure in chemotherapeutic treatments. We have previously shown that the level of labeling with Hoechst 33342 and rhodamine 123 in established cell lines was decreased in cells with 'classic' MDR phenotype. This functional test was carried out using fluorescence image cytometry on living cells. We applied this protocol to patients with chronic lymphocytic leukemia. Although a large variability of the labeling is observed in cells from healthy donors, this approach seems to be useful for early detection of P-gp-dependent resistance in leukemia cells and for identification of new reversing agents on patient lymphocytes.
耐药性的产生是化疗失败的主要原因。我们之前已经表明,在具有“经典”多药耐药(MDR)表型的细胞中,已建立的细胞系中用Hoechst 33342和罗丹明123标记的水平降低。这种功能测试是在活细胞上使用荧光图像细胞术进行的。我们将该方案应用于慢性淋巴细胞白血病患者。尽管在健康供体的细胞中观察到标记存在很大差异,但这种方法似乎有助于早期检测白血病细胞中P-糖蛋白依赖性耐药性,并有助于鉴定患者淋巴细胞上的新型逆转剂。